AccessPak for HIV PEP Expanded with Kaletra and Insulin glargine and lixisenatide
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Insulin glargine and lixisenatide Subcutaneous
- AccessPak for HIV PEP Expanded with Kaletra-Insulin glargine, recombinant Subcutaneous
- AccessPak for HIV PEP Expanded with Kaletra-Insulin glulisine
- AccessPak for HIV PEP Expanded with Kaletra-Insulin Glulisine (Cartridges and Pens)
- AccessPak for HIV PEP Expanded with Kaletra-Insulin Glulisine (Vials)
- AccessPak for HIV PEP Expanded with Kaletra-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-AccessPak for HIV PEP Expanded with Viracept
- Insulin glargine and lixisenatide-Accolate
- Insulin glargine and lixisenatide-Accretropin
- Insulin glargine and lixisenatide-Accucaine
- Insulin glargine and lixisenatide-AccuHist Drops
- Insulin glargine and lixisenatide-AccuHist PDX Drops